Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast Cancer Promising early results with pembrolizumab, nivolumab but event-free survival data still pending Dec 07, 2023
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug News, features, and commentary about cancer-related issues Dec 07, 2023
The Treatment Landscape for Cervical Cancer Has Changed Our experts discuss the impact of new options and approaches available in the field Dec 07, 2023 video
No Benefit to Adjuvant-Only Immunotherapy in Early TNBC Neoadjuvant administration of immunotherapy remains the preferred approach Dec 07, 2023
De-Escalating Breast Cancer Treatment Feasible After Response to Neoadjuvant Chemo Study showed no increase in disease progression when omitting regional nodal irradiation Dec 07, 2023
Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancer Adding agent to T-DM1 resulted in 2-month progression-free survival improvement Dec 06, 2023
FDA Approves Oral Factor B Inhibitor for Paroxysmal Nocturnal Hemoglobinuria Iptacopan tops C5 Inhibitors for sustained hemoglobin levels, eliminating need for transfusion Dec 06, 2023
TULSA Effective in Controlling Prostate Cancer Long-Term At 5 years, median PSA was reduced by 90% Dec 05, 2023
Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCL Patients with treatment-sensitive disease may benefit most from continued treatment, says expert Dec 05, 2023
After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasms Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge Dec 04, 2023
Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene? Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years Dec 04, 2023
Non-Covalent BTK Inhibitor Approved for CLL Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
Charting the Course: From Young Adult Leukemia Patient to Oncologist My experience shaped how I care for patients today Dec 03, 2023
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
Breast Cancer Screening Frequency Makes a Big Survival Difference Keeping those mammogram appointments is life-saving, study finds Nov 30, 2023
Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer And our roundtable of experts discuss selinexor for wild-type p53 disease Nov 30, 2023 video
AI Model Can Predict Breast Cancer Risk Regardless of Patient's Race Algorithm proved accurate where traditional risk models have failed, but needs more testing Nov 30, 2023
With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokers Tool could identify nonsmokers most likely to benefit from low-dose CT screening Nov 29, 2023
FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screening The strategy was effective for patients who were due or overdue for screening Nov 28, 2023
FDA Approves First Therapy for Progressive Desmoid Tumors Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
Cancer Patient's Final Act: Destroying Medical Debt Viral campaign will erase some $60 million in medical debt Nov 22, 2023
Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gaza Health news and commentary from around the Web gathered by staff Nov 22, 2023
HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapse Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL However, it may benefit children at increased risk of thrombosis Nov 20, 2023
Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort No excess brain bleeds in an Asian population receiving lytic therapy for stroke Nov 20, 2023
Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceled Health news and commentary from around the Web gathered by staff Nov 20, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
First AKT Inhibitor Approved for Advanced Breast Cancer Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023
